Унгария - унгарски - OGYÉI (Országos Gyógyszerészeti és Élelmezés-egészségügyi Intézetről)

human bioplazma kft. - humán albumin oldat -

Швеция - шведски - Läkemedelsverket (Medical Products Agency)

biotest pharma gmbh - albumin, humant - infusionsvätska, lösning - 200 g/l - albumin, humant 200 g aktiv substans - albumin

Швеция - шведски - Läkemedelsverket (Medical Products Agency)

baxalta innovations gmbh - albumin, humant - infusionsvätska, lösning - 200 g/l - albumin, humant 200 g aktiv substans - albumin

Швеция - шведски - Läkemedelsverket (Medical Products Agency)

baxalta innovations gmbh - albumin, humant - infusionsvätska, lösning - 50 g/l - albumin, humant 50 g aktiv substans - albumin

Швеция - шведски - Läkemedelsverket (Medical Products Agency)

ge healthcare as - albumin, joderat (i-125) humant - injektionsvätska, lösning - 8-22 mbq/ml - albumin, joderat (i-125) humant 8 - 22 mbq aktiv substans; bensylalkohol hjälpämne - humant jod(i-125)albumin

Швеция - шведски - Läkemedelsverket (Medical Products Agency)

octapharma ab - albumin, humant - infusionsvätska, lösning - 200 g/l - albumin, humant 200 mg aktiv substans - albumin

Швеция - шведски - Läkemedelsverket (Medical Products Agency)

csl behring gmbh - albumin, humant - infusionsvätska, lösning - 50 g/l - albumin, humant 50 mg aktiv substans - albumin

Швеция - шведски - Läkemedelsverket (Medical Products Agency)

octapharma ab - albumin, humant - infusionsvätska, lösning - 50 g/l - albumin, humant 50 mg aktiv substans - albumin

САЩ - английски - NLM (National Library of Medicine)

grifols usa, llc - albumin human (unii: zif514rvzr) (albumin human - unii:zif514rvzr) - albumin human 2.5 g in 50 ml - emergency treatment of hypovolemic shock plasbumin-5 is iso-oncotic with normal plasma and on intravenous infusion will expand the circulating blood volume by an amount approximately equal to the volume infused. in conditions associated mainly with a volume deficit, albumin is best administered as a 5% solution (plasbumin-5); but where there is an oncotic deficit, albumin (human) 25%, usp (plasbumin® -25) may be preferred. this is also an important consideration where the treatment of the shock state has been delayed. if plasbumin-25 is used, appropriate additional crystalloid should be administered.(1) crystalloid solutions in volumes several times greater than that of plasbumin-5 may be effective in treating shock in younger individuals who have no preexisting illness at the time of the incident. older patients, especially those with preexisting debilitating conditions, or those in whom the shock is caused by a medical disorder, or where the state of shock has existed for some time before active therapy cou

САЩ - английски - NLM (National Library of Medicine)

kedrion biopharma, inc. - albumin human (unii: zif514rvzr) (albumin human - unii:zif514rvzr) - albumin human 2.5 g in 50 ml - emergency treatment of hypovolemic shock albuked 5 is iso-oncotic with normal plasma and on intravenous infusion will expand the circulating blood volume by an amount approximately equal to the volume infused. in conditions associated mainly with a volume deficit, albumin is best administered as a 5% solution (albuked 5); but where there is an oncotic deficit, albumin (human) 25%, usp (albuked™ 25) may be preferred. this is also an important consideration where the treatment of the shock state has been delayed. if albuked 25 is used, appropriate additional crystalloid should be administered.(1) crystalloid solutions in volumes several times greater than that of albuked 5 may be effective in treating shock in younger individuals who have no preexisting illness at the time of the incident. older patients, especially those with preexisting debilitating conditions, or those in whom the shock is caused by a medical disorder, or where the state of shock has existed for some time before active therapy could be insti